Notice for penpulimab (Specialised Therapeutics Pharma Pty Ltd)
Active ingredients
penpulimab
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Solution for intravenous infusion
Indication
Treatment of nasopharyngeal carcinoma
Therapeutic area
Oncology